Pharma Journalist -

Acadia Pharmaceuticals Inc. announced it has entered into an exclusive worldwide license agreement with Saniona for the development and commercialization of SAN711, a first-in-class,…
Read More...

Roche announced today that it has entered into a definitive merger agreement to acquire Poseida Therapeutics, Inc., a public clinical-stage biopharmaceutical company pioneering…
Read More...

Sarepta Therapeutics, Inc. announced an exclusive global licensing and collaboration agreement with Arrowhead Pharmaceuticals, Inc. Sarepta will obtain exclusive global rights to…
Read More...

Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, Germany, has acquired Baccinex, a Swiss-based expert in…
Read More...

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s supplemental New…
Read More...

Eton Pharmaceuticals, Inc. an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it has acquired the U.S. rights to…
Read More...

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced that the FDA has approved IMKELDI (imatinib) oral solution, the first oral liquid form of imatinib…
Read More...

GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of Arexvy (respiratory syncytial virus…
Read More...

Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. announced they have entered into a global strategic collaboration to develop and commercialize ziftomenib, Kura's selective oral menin…
Read More...

Zai Lab and Pfizer announced a strategic collaboration for the novel antibacterial drug XACDURO (sulbactam-durlobactam) in mainland China. Pfizer’s affiliated companies will be…
Read More...